Cognizant (CTSH) director receives dividend-based restricted stock units grant

Rhea-AI Filing Summary

Cognizant Technology Solutions director Karima Silvent reported an automatic equity accrual tied to existing awards. On the reported date, Silvent acquired 14.6635 restricted stock units through dividend equivalent rights on previously outstanding restricted stock units, at a stated price of $0 per unit.

Each restricted stock unit represents a contingent right to receive one share of the company’s Class A common stock. Following this accrual, Silvent directly holds a total of 2,901.6140 restricted stock units, which are scheduled to vest in full on June 3, 2026, subject to the applicable award terms.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Silvent Karima

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	14.664	$0.00	--

Holdings After Transaction: Restricted Stock Units — 2,901.614 shares (Direct)

Footnotes (1)

1. Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. The restricted stock units will vest fully on June 3, 2026.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silvent Karima

(Last) (First) (Middle)

C/O COGNIZANT TECHNOLOGY SOLUTIONS CORP.

300 FRANK W. BURR BLVD., STE. 36, 6 FL.

(Street)

TEANECK NJ 07666

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNIZANT TECHNOLOGY SOLUTIONS CORP [ CTSH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/26/2026		A(1)		14.6635		(2)	(2)	Class A Common Stock	14.6635	$0	2,901.614	D

Explanation of Responses:

1. Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company.

2. The restricted stock units will vest fully on June 3, 2026.

Remarks:

	/s/ Melissa Glass, on behalf of Karima Silvent, by Power of Attorney	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cognizant (CTSH) director Karima Silvent report?

Karima Silvent reported acquiring 14.6635 restricted stock units through dividend equivalent rights. These units were added to previously outstanding awards and involve no cash purchase, reflecting automatic equity-based compensation rather than an open-market stock transaction.

How many Cognizant (CTSH) restricted stock units does Karima Silvent hold after this Form 4?

After the reported transaction, Karima Silvent directly holds 2,901.6140 restricted stock units. This total includes the 14.6635 units credited via dividend equivalent rights, representing contingent rights to receive Class A common shares, subject to vesting conditions.

What are the terms of the new Cognizant (CTSH) restricted stock units reported?

The reported restricted stock units were received under dividend equivalent rights on existing awards. Each unit represents a contingent right to one share of Class A common stock and is scheduled to vest fully on June 3, 2026, if the award conditions are satisfied.

Did Karima Silvent buy or sell Cognizant (CTSH) shares in this Form 4?

The filing reports an acquisition of restricted stock units via a grant-type transaction, not an open-market buy or sale. The units were credited automatically through dividend equivalent rights associated with previously granted restricted stock units.

When will Karima Silvent’s newly reported Cognizant (CTSH) restricted stock units vest?

The restricted stock units reported in the Form 4 are scheduled to vest fully on June 3, 2026. At vesting, each unit is designed to convert into one share of Cognizant’s Class A common stock, assuming all award conditions are met.